Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Dissolving or eluting from solid or gel matrix
Patent
1992-01-28
1994-05-24
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Dissolving or eluting from solid or gel matrix
600 4, 600 7, 424 161, A61K 4300, A61K 4902
Patent
active
053146786
ABSTRACT:
The present invention relates to radiopharmaceutical products used in the treatment of thyroid diseases. In particular, the present invention relates to sodium iodide .sup.131 I capsules which have increased stability and lower volatility.
The objects of the present invention are achieved by providing a .sup.131 I capsule having a matrix material and antioxidant additive combination which provides for increased stability and reduced volatility of the capsule.
REFERENCES:
patent: 2911338 (1959-11-01), Tabern et al.
patent: 3121041 (1964-02-01), Stern et al.
patent: 3159545 (1964-12-01), Kidwell et al.
patent: 3421282 (1969-01-01), Hasegawa et al.
patent: 4698101 (1987-10-01), Koivurinta
patent: 5049374 (1991-09-01), Dansereau et al.
patent: 5137723 (1992-08-01), Yamamoto et al.
Grummon Glenn D.
Helling David E.
Covert John M.
Hey David A.
Mallinckrodt Medical Inc.
Stierwalt Brian K.
Stoll Robert L.
LandOfFree
Sodium iodide .sup.131 I capsules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sodium iodide .sup.131 I capsules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sodium iodide .sup.131 I capsules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1971308